Artivion, Inc. NYSE:AORT

Artivion stock price today

$42.02
+13.02
+44.9%
Financial Health
0
1
2
3
4
5
6
7
8
9

Artivion stock price monthly change

+6.30%
month

Artivion stock price quarterly change

+6.30%
quarter

Artivion stock price yearly change

+58.99%
year

Artivion key metrics

Market Cap
1.18B
Enterprise value
860.79M
P/E
-27.63
EV/Sales
2.74
EV/EBITDA
33.51
Price/Sales
1.73
Price/Book
1.91
PEG ratio
1.04
EPS
-0.24
Revenue
368.20M
EBITDA
32.55M
Income
-9.62M
Revenue Q/Q
17.06%
Revenue Y/Y
15.13%
Profit margin
-6.12%
Oper. margin
1.98%
Gross margin
64.54%
EBIT margin
1.98%
EBITDA margin
8.84%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Artivion stock price history

Artivion stock forecast

Artivion financial statements

Average Price Target
Last Year

$31.5

Potential downside: -25.03%

Based on estimate of 2 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Artivion, Inc. (NYSE:AORT): Profit margin
Jun 2023 89.25M -3.38M -3.79%
Sep 2023 87.85M -9.80M -11.16%
Dec 2023 93.67M -3.97M -4.24%
Mar 2024 97.43M 7.53M 7.73%
Artivion, Inc. (NYSE:AORT): Debt to assets
Jun 2023 777861000 495.35M 63.68%
Sep 2023 774787000 502.81M 64.9%
Dec 2023 792397000 510.61M 64.44%
Mar 2024 784007000 489.02M 62.37%
Artivion, Inc. (NYSE:AORT): Cash Flow
Jun 2023 6.90M 7.07M 2.23M
Sep 2023 7.23M -2.06M -909K
Dec 2023 10.58M -2.66M -1.38M
Mar 2024 -15.49M -3.61M 10.73M

Artivion alternative data

Artivion, Inc. (NYSE:AORT): Employee count
Aug 2023 1,300
Sep 2023 1,300
Oct 2023 1,300
Nov 2023 1,300
Dec 2023 1,300
Jan 2024 1,300
Feb 2024 1,300
Mar 2024 1,500
Apr 2024 1,500
May 2024 1,500
Jun 2024 1,500
Jul 2024 1,500

Artivion other data

85.74% -0.82%
of AORT is owned by hedge funds
34.16M +425.57K
shares is hold by hedge funds

Artivion, Inc. (NYSE:AORT): Insider trades (number of shares)
Period Buy Sel
Jan 2024 0 34791
Feb 2024 0 107355
Mar 2024 0 61699
May 2024 0 2229
Aug 2024 0 24679
Oct 2024 0 12430
Dec 2024 0 16372
Transaction Date Insider Security Shares Price per share Total value Source
Sale
HORTON AMY officer: VP, Chief Accounting O..
Common Stock 4,329 $29.66 $128,398
Sale
HORTON AMY officer: VP, Chief Accounting O..
Common Stock 4,425 $29.05 $128,551
Sale
GREEN ANDREW M officer: VP Regulatory
Common Stock 7,618 $30 $228,540
Option
HORTON AMY officer: VP, Chief Accounting O..
Common Stock 12,430 $21.55 $267,867
Sale
HORTON AMY officer: VP, Chief Accounting O..
Common Stock 12,430 $26.18 $325,417
Option
HORTON AMY officer: VP, Chief Accounting O..
Stock Option (Right to Buy) 12,430 $21.55 $267,867
Sale
HOLLOWAY JEAN F officer: SVP, Gen.. Common Stock 3,167 $26.55 $84,097
Sale
GETZ MATTHEW A officer: VP, Human Resources
Common Stock 6,858 $25.31 $173,590
Sale
GETZ MATTHEW A officer: VP, Human Resources
Common Stock 2,562 $25.31 $64,849
Sale
HOLLOWAY JEAN F officer: SVP, Gen.. Common Stock 2,383 $25.76 $61,393
Monday, 9 December 2024
techcrunch.com
prnewswire.com
Saturday, 9 November 2024
seekingalpha.com
Thursday, 7 November 2024
zacks.com
prnewswire.com
Tuesday, 5 November 2024
prnewswire.com
Thursday, 24 October 2024
prnewswire.com
Thursday, 10 October 2024
prnewswire.com
Saturday, 10 August 2024
seekingalpha.com
Thursday, 8 August 2024
zacks.com
prnewswire.com
Monday, 5 August 2024
prnewswire.com
Thursday, 25 July 2024
prnewswire.com
Wednesday, 3 July 2024
investorplace.com
Monday, 1 July 2024
prnewswire.com
Friday, 21 June 2024
seekingalpha.com
Wednesday, 8 May 2024
Zacks Investment Research
Monday, 6 May 2024
Seeking Alpha
Zacks Investment Research
Monday, 15 April 2024
Zacks Investment Research
Friday, 29 March 2024
Zacks Investment Research
Thursday, 28 March 2024
Zacks Investment Research
Tuesday, 19 March 2024
Zacks Investment Research
Thursday, 14 March 2024
Zacks Investment Research
Tuesday, 12 March 2024
Zacks Investment Research
Thursday, 22 February 2024
Zacks Investment Research
Zacks Investment Research
Wednesday, 21 February 2024
Zacks Investment Research
Thursday, 15 February 2024
Seeking Alpha
Zacks Investment Research
  • What's the price of Artivion stock today?

    One share of Artivion stock can currently be purchased for approximately $42.02.

  • When is Artivion's next earnings date?

    Unfortunately, Artivion's (AORT) next earnings date is currently unknown.

  • Does Artivion pay dividends?

    No, Artivion does not pay dividends.

  • How much money does Artivion make?

    Artivion has a market capitalization of 1.18B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 12.82% to 354M US dollars.

  • What is Artivion's stock symbol?

    Artivion, Inc. is traded on the NYSE under the ticker symbol "AORT".

  • What is Artivion's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Artivion?

    Shares of Artivion can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Artivion have?

    As Jul 2024, Artivion employs 1,500 workers.

  • When Artivion went public?

    Artivion, Inc. is publicly traded company for more then 32 years since IPO on 12 Feb 1993.

  • What is Artivion's official website?

    The official website for Artivion is artivion.com.

  • Where are Artivion's headquarters?

    Artivion is headquartered at 1655 Roberts Boulevard N.W., Kennesaw, GA.

  • How can i contact Artivion?

    Artivion's mailing address is 1655 Roberts Boulevard N.W., Kennesaw, GA and company can be reached via phone at +7 704193355.

  • What is Artivion stock forecast & price target?

    Based on 2 Wall Street analysts` predicted price targets for Artivion in the last 12 months, the avarage price target is $31.5. The average price target represents a -25.03% change from the last price of $42.02.

Artivion company profile:

Artivion, Inc.

artivion.com
Exchange:

NYSE

Full time employees:

1,500

Industry:

Medical - Devices

Sector:

Healthcare

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. The company was founded in 1984 and is headquartered in Kennesaw, Georgia.

1655 Roberts Boulevard N.W.
Kennesaw, GA 30144

CIK: 0000784199
ISIN: US2289031005
CUSIP: 228903100